Rasi Bhadramani
- Akero Rehabs ( NASDAQ: AKRO) is up ~ 5% in after-hours trading Friday after revealing it will hold a teleconference Jan. 27 to talk about topline arise from a stage 2b research study of efruxifermin in clients with compensated cirrhosis due to metabolic
Source: Business Insider.